Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab (vol 10, pg 743, 2018)

被引:0
|
作者
Bersanelli, Melissa
Gnetti, Letizia
Azzoni, Cinzia
Bottarelli, Lorena
Sverzellati, Nicola
Campanini, Nicoletta
Varotti, Elena
Corrado, Michele
Parziale, Raffaele
Rapacchi, Elena
Caruso, Giuseppe
Leonardi, Francesco
Silini, Enrico Maria
Buti, Sebastiano
机构
关键词
D O I
10.2217/imt-2017-0160c1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1287 / 1288
页数:2
相关论文
共 50 条
  • [41] The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer (vol 53, pg 227, 2018)
    Yoon, Seug Yun
    Lee, Min-Young
    Yun, Jina
    Kim, Han Jo
    Kim, Kyoung-Ha
    Kim, Se Hyung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan-Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Hong, Dae Sik
    Won, Jong-Ho
    BLOOD RESEARCH, 2018, 53 (04) : 335 - 336
  • [42] Frequency and characteristics of drowsiness, somnolence, or daytime sleepiness in patients with advanced cancer (vol 17, pg 1, 2018)
    Yennurajalingam, Sriram
    Barla, Srikanth Reddy
    Arthur, Joseph
    Chisholm, Gary B.
    Bruera, Eduardo
    PALLIATIVE & SUPPORTIVE CARE, 2019, 17 (01) : 126 - 126
  • [43] miR-199b-5p serves as a tumor suppressor in renal cell carcinoma (vol 16,Pg 436-444, 2018)
    Lai, Yulin
    Quan, Jing
    Lin, Canbin
    Li, Hang
    Hu, Jia
    Chen, Peijie
    Xu, Jinling
    Guan, Xin
    Xu, Weijie
    Lai, Yongqing
    Ni, Liangchao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (04)
  • [44] DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer (vol 18, pg 43, 2015)
    Li, Zheng
    Lei, Huizi
    Luo, Min
    Wang, Yi
    Dong, Lei
    Ma, Yanni
    Liu, Changzheng
    Song, Wei
    Wang, Fang
    Zhang, Junwu
    Shen, Jianxiong
    Yu, Jia
    GASTRIC CANCER, 2022, 25 (06) : 1136 - 1138
  • [45] Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II (vol 46, pg 949, 2018)
    Tumlin, J. A.
    Murugan, R.
    Deane, A. M.
    CRITICAL CARE MEDICINE, 2018, 46 (08) : E824 - E824
  • [46] Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases (vol 116, pg 62, 2018)
    Gauvain, Clement
    Vauleon, Enora
    Chouaid, Christos
    Le Rhun, Emilie
    Jabot, Laurence
    Scherpereel, Arnaud
    Vinas, Florent
    Cortot, Alexis Benjamin
    Monnet, Isabelle
    LUNG CANCER, 2019, 136 : 159 - 159
  • [47] Peperomin E reactivates silenced tumor suppressor genes in lung cancer cells by inhibition of DNA methyltransferase (vol 107, pg 1506, 2016)
    Wang, Xin-zhi
    Cheng, Ying
    Wang, Kui-long
    Liu, Rui
    Yang, Xiao-lin
    Wen, Hong-mei
    Chai, Chuan
    Liang, Jing-yu
    Wu, Hao
    CANCER SCIENCE, 2020, 111 (03) : 1032 - 1033
  • [48] Long-term survival in patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab
    Topalian, Suzanne L.
    Hodi, F. Stephen
    Brahmer, Julie R.
    Gettinger, Scott N.
    Smith, David C.
    McDermott, David F.
    Powderly, John D.
    Sosman, Jeffrey A.
    Atkins, Michael B.
    Spigel, David R.
    Antonia, Scott J.
    Drilon, Alexander
    Bhore, Rafia
    Hosein, Fareeda
    Sznol, Mario
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [50] PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
    Guibert, Nicolas
    Delaunay, Myriam
    Lusque, Annelle
    Boubekeur, Nadia
    Rouquette, Isabelle
    Clermont, Estelle
    Mourlanette, Jean
    Gouin, Sandrine
    Dormoy, Inge
    Favre, Gilles
    Mazieres, Julien
    Pradines, Anne
    LUNG CANCER, 2018, 120 : 108 - 112